Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, has accepted and granted Priority Review designation ...

K12 educator in any content area. Priority acceptance granted to Wyoming K-12 teachers who have not previously atteneded ESP4T. Previous participants encouraged to apply and will be asked to share ...

April 01, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (APLS) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review designation of the ...